{"id":435,"date":"2023-08-25T14:54:04","date_gmt":"2023-08-25T06:54:04","guid":{"rendered":"https:\/\/consulting-hmk.com\/?p=435"},"modified":"2024-01-18T09:47:23","modified_gmt":"2024-01-18T01:47:23","slug":"eg-5-most-prominent-substrain-of-covid-19","status":"publish","type":"post","link":"https:\/\/www.consulting-hmk.com\/pt\/eg-5-most-prominent-substrain-of-covid-19\/","title":{"rendered":"EG.5 Sub-ra\u00e7a mais proeminente de COVID-19"},"content":{"rendered":"<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 A subestirpe EG.5 da variante Omicron da COVID-19 tornou-se a fonte mais proeminente de infec\u00e7\u00f5es por coronav\u00edrus na China, informou no s\u00e1bado o Centro Chin\u00eas de Controlo e Preven\u00e7\u00e3o de Doen\u00e7as.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-387 aligncenter\" title=\"EG.5 Sub-ra\u00e7a mais proeminente de COVID-19\" src=\"https:\/\/consulting-hmk.com\/wp-content\/uploads\/2023\/08\/NMPA-News-1-300x67.png\" alt=\"EG.5 Sub-ra\u00e7a mais proeminente de COVID-19\" width=\"999\" height=\"223\" srcset=\"https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/NMPA-News-1-300x67.png 300w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/NMPA-News-1-1024x228.png 1024w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/NMPA-News-1-768x171.png 768w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/NMPA-News-1.png 1435w\" sizes=\"(max-width: 999px) 100vw, 999px\" \/><\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 O n\u00famero de infec\u00e7\u00f5es por COVID-19 causadas pelo EG.5 na China aumentou para 71,6% este m\u00eas, contra apenas 0,6% em abril, disse o centro, acrescentando que a Organiza\u00e7\u00e3o Mundial de Sa\u00fade classificou o EG.5 como uma variante de interesse, mas disse que n\u00e3o representava uma amea\u00e7a maior do que outras variantes.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 O CDC da China afirmou que as pessoas infectadas com a subesp\u00e9cie XBB da Omicron entre abril e junho teriam imunidade contra a EG.5.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-358 aligncenter\" title=\"EG.5 Sub-ra\u00e7a mais proeminente de COVID-19\" src=\"https:\/\/consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-300x169.jpg\" alt=\"EG.5 Sub-ra\u00e7a mais proeminente de COVID-19\" width=\"601\" height=\"338\" srcset=\"https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-300x169.jpg 300w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-1024x576.jpg 1024w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-768x432.jpg 768w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-1536x864.jpg 1536w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/07\/vecteezy_professional-doctors-are-using-intelligence-to-diagnose-and_9377700_508-2048x1152.jpg 2048w\" sizes=\"(max-width: 601px) 100vw, 601px\" \/><\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 Al\u00e9m disso, a propaga\u00e7\u00e3o do EG.5 n\u00e3o exerceu qualquer press\u00e3o sobre os sistemas m\u00e9dicos at\u00e9 \u00e0 data e \u00e9 pouco prov\u00e1vel que conduza a surtos em grande escala, acrescentou.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 O CDC afirmou ainda n\u00e3o haver provas de que o EG.5 possa causar sintomas graves, apesar do aumento do n\u00famero de pessoas infectadas internadas em hospitais de pa\u00edses como o Jap\u00e3o, a Coreia do Sul e os Estados Unidos.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 O Diretor-Geral da OMS, Tedros Adhanom Ghebreyesus, afirmou que, embora o risco global seja baixo, com base nas suas caracter\u00edsticas gen\u00e9ticas, nas caracter\u00edsticas do escape imunit\u00e1rio e nas estimativas da taxa de crescimento, o EG.5 pode propagar-se a n\u00edvel mundial e contribuir para um aumento do n\u00famero de casos.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 O centro aconselhou ainda os idosos e as pessoas que sofrem de doen\u00e7as subjacentes graves a protegerem-se melhor, usando m\u00e1scaras nos transportes p\u00fablicos ou em espa\u00e7os p\u00fablicos fechados.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>A subestirpe EG.5 da variante Omicron da COVID-19 tornou-se a fonte mais proeminente de infec\u00e7\u00f5es por coronav\u00edrus na China, informou no s\u00e1bado o Centro Chin\u00eas de Controlo e Preven\u00e7\u00e3o de Doen\u00e7as.<\/p>","protected":false},"author":4,"featured_media":436,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[70],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/posts\/435"}],"collection":[{"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/comments?post=435"}],"version-history":[{"count":0,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/posts\/435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/media\/436"}],"wp:attachment":[{"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/media?parent=435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/categories?post=435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/pt\/wp-json\/wp\/v2\/tags?post=435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}